Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use

CONTEXT: Teriparatide and denosumab are effective treatments for osteoporosis and typically reserved as second-line options after patients have used bisphosphonates. However, limited head-to-head comparative effectiveness data exist between teriparatide and denosumab. OBJECTIVE: We compared changes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Autores principales: Lyu, Houchen, Zhao, Sizheng S, Yoshida, Kazuki, Tedeschi, Sara K, Xu, Chang, Nigwekar, Sagar U, Leder, Benjamin Z, Solomon, Daniel H
Formato: Artigo
Lenguaje:Inglês
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785688/
https://ncbi.nlm.nih.gov/pubmed/31265071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2019-00924
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares